Correlation Between Visa and PYC Therapeutics

Can any of the company-specific risk be diversified away by investing in both Visa and PYC Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and PYC Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Visa Class A and PYC Therapeutics, you can compare the effects of market volatilities on Visa and PYC Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of PYC Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and PYC Therapeutics.

Diversification Opportunities for Visa and PYC Therapeutics

-0.34

Correlation Coefficient

Visa  PYC Therapeutics

Very good diversification

The 3 months correlation between Visa and PYC is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and PYC Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PYC Therapeutics and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with PYC Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PYC Therapeutics has no effect on the direction of Visa i.e., Visa and PYC Therapeutics go up and down completely randomly.

Pair Corralation between Visa and PYC Therapeutics

Taking into account the 90-day investment horizon Visa is expected to generate 1.38 times less return on investment than PYC Therapeutics. But when comparing it to its historical volatility, Visa Class A is 3.9 times less risky than PYC Therapeutics. It trades about 0.14 of its potential returns per unit of risk. PYC Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  120.00  in PYC Therapeutics on September 27, 2024 and sell it today you would earn a total of  20.00  from holding PYC Therapeutics or generate 16.67% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	97.66%
Values	Daily Returns

Visa Class A  vs.  PYC Therapeutics

Visa Class A

Risk-Adjusted Performance

18 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Visa showed solid returns over the last few months and may actually be approaching a breakup point.

PYC Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days PYC Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Visa and PYC Therapeutics

The main advantage of trading using opposite Visa and PYC Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, PYC Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PYC Therapeutics will offset losses from the drop in PYC Therapeutics' long position.

The idea behind Visa Class A and PYC Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.